Rebecca Obeng, PhD, MD, FASCP

Class Year




Posted on: July 14, 2020

Rebecca Obeng, PhD ’11, MD ’13, FASCP, of Woodbridge, Va., is among 40 high-achieving pathologists, pathology residents, and medical laboratory professionals under age 40 who have been named to the prestigious 2020 American Society for Clinical Pathology (ASCP) 40 Under Forty list.

ASCP’s 40 Under Forty program shines the spotlight on 40 highly accomplished pathologists, pathology residents and laboratory professionals under age 40 who have already made significant contributions to the profession and stand out as leaders who will help shape the future of pathology and laboratory medicine on behalf of patients.

Dr. Obeng is a board-certified anatomic pathologist scientist with a subspecialty interest in gastrointestinal and oncologic pathology. Her research focus is on T-cell immunology and cancer immunotherapy. She also has interests in global health and health policy. Dr. Obeng completed her medical and graduate education at the University of Virginia School of Medicine and then completed an anatomic pathology residency at Emory University in the Physician Scientist Training Track. She continued at Emory University for fellowship training in gastrointestinal and hepatic pathology and a post-doctoral research fellowship. She is currently an assistant professor in the Department of Pathology at Northwestern University and serves as the chief medical officer of the Sub-Saharan Africa Healthcare Initiative. Dr. Obeng is passionate about improving the quality of patients’ lives by exploring creative new approaches and techniques in pathology and immunology that advance the understanding of diseases and the ability to clinically manage patients.

“ASCP’s 40 Under Forty program is an opportunity to recognize young pathology and medical laboratory leaders from around the globe,” said ASCP President Gene Siegal, MD, PhD, FASCP. “By providing support and encouragement to these young professionals, we aim to strengthen the medical laboratory workforce during this historic period in global health. We are very fortunate to have such a talented group of individuals – they will help to shape the future of patient care.”